Dissection of Thoracic Aorta Clinical Trial
Verified date | July 2014 |
Source | Yonsei University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Korea: Food and Drug Administration |
Study type | Observational |
Acute kidney injury (AKI) is one of the most frequently encountered and prognostically
significant complications after cardiovascular surgery. However, there is no definitive
treatment to intervene after development of AKI, therefore, preventive strategy has been the
major issue. By this time, incidence of AKI after cardiovascular surgery has been reported
3-50% based on the studies with various definition of AKI and different patient cohorts.
Development of unified definition for AKI in the early 2000s opened a new era in AKI study.
According to the previous studies, aortic surgery, especially thoracic aortic surgery was
known to be highly prevalent of AKI, which was considered to be caused by use of total
circulatory arrest (TCA), relatively high number of emergency cases, combined malperfusion
syndrome before surgery and relatively complicated surgical procedure. However, there has
not been many studies of AKI in thoracic aortic surgery because of its low incidence and
urgent clinical presentation of aortic pathology, which hinder large randomized controlled
study. Moreover, there are conflicting reports of incidence and risk factors of AKI after
thoracic aortic surgery, no conclusive result has been made. Therefore, this study was
designed to investigate the incidence and risk factors after thoracic aortic surgery only
due to dissection.
Status | Completed |
Enrollment | 100 |
Est. completion date | January 2013 |
Est. primary completion date | January 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - thoracic aortic surgery due to dissection Exclusion Criteria: - chronic kidney disease on renal replacement therapy before surgery - death during or within 24 hours after surgery |
Observational Model: Cohort, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Gangnam Severance Hospital | Seoul |
Lead Sponsor | Collaborator |
---|---|
Yonsei University |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | incidence of acute kidney injury based of RIFLE criteria | serum creatinine, GFR were retrospectively retrieved from electrical medical record upto 7days after surgery. | upto 7 days after surgery | No |
Secondary | Risk factors of acute kidney injury | age, sex, comorbidities serum creatinine, hemoglobin,mean arterial blood pressure CPB duration, aorta cross clamping duration, total circulatory arrest duration, operative procedures performed, amount of transfused blood components serum creatinine upto 7 days after surgery, mean arterial pressure, cardiac index, amount of transfused blood components in intensive care unit, ventiltor duration, ICU stay duration, renal replacement therapy, 30-day mortality |
after diagnosis of acute kidney injury after operation (usually within 7 days after operation) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05639569 -
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
|
||
Completed |
NCT01369732 -
Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest
|
Phase 4 | |
Active, not recruiting |
NCT05030740 -
French Assessment of the Relay Plus and Relay NBS Plus Thoracic Stent-Graft
|
||
Recruiting |
NCT03322033 -
Feasibility of Endovascular Repair of Ascending Aortic Pathologies
|
N/A |